CoChat
Sign Up
Cited by 28

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Designing a drug delivery system for improved tumor treatment and targeting by functionalization of a cell-penetrating peptide

Al-azzawi, Shafq, Masheta, Dhafir·2019·Journal of Pharmaceutical Investigation
DOI 10.1007/s40005-018-00424-w
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1007/s40005-018-00424-w

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 1 references

Research works printed but not linked: 48

  1. Al-Azzawi S, Masheta D, Guildford AL, Phillips G, Santin M (2018) Dendrimeric poly(epsilon-lysine) delivery systems for the enhanced permeability of flurbiprofen across the blood-brain barrier in Alzheimer’s disease. Int J Mol Sci. https://doi.org/10.3390/ijms19103224 · DOI · Paper page
  2. Bechara C, Sagan S (2013) Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett 587(12):1693–1702. https://doi.org/10.1016/j.febslet.2013.04.031 · DOI
  3. Bolhassani A, Jafarzade B, Mardani G (2017) In vitro and in vivo delivery of therapeutic proteins using cell penetrating peptides. Peptides 87:50–63. https://doi.org/10.1016/j.peptides.2016.11.011 · DOI
  4. Chung EJ, Cheng Y, Morshed R, Nord K, Han Y et al (2014) Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma. Biomaterials 35(4):1249–1256. https://doi.org/10.1016/j.biomaterials.2013.10.064 · DOI
  5. Cooley C, Wender P, Geihe E (2012) Beyond cell penetrating peptides: designed molecular transporters. Dr Discov Today Technol 9(1):e49–e55. https://doi.org/10.1016/j.ddtec.2011.07.004 · DOI
  6. D’souza AJ, Topp EM (2004) Release from polymeric prodrugs: linkages and their degradation. J Pharm Sci 93(8):1962–1979. https://doi.org/10.1002/jps.20096 · DOI
  7. Diop N, Zhao R, Visentin M, Goldman ID (2011) Mechanisms of membrane transport of folates into cells and across epithelia. Ann Rev Nutr. https://doi.org/10.1146/annurev-nutr-072610-145133 · DOI
  8. Dissanayake S, Denny WA, Gamage S, Sarojini V (2017) Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides. J Control Rel 250:62–76. https://doi.org/10.1016/j.jconrel.2017.02.006 · DOI
  9. Dubikovskaya A, Thorne H, Pillow H, Contag H, Wender A (2008) Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters. Proc Natl Acad Sci 105(34):12128–12133. https://doi.org/10.1073/pnas.0805374105 · DOI
  10. Garg N, Singh B, Jain A, Nirbhavane P, Sharma R et al (2016) Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics. Colloids Surf B Biointerfaces 146:114–126. https://doi.org/10.1016/j.colsurfb.2016.05.051 · DOI
  11. Ghaz A, Abbaspour F, Anarjan N, Berenjian A, Jafarizadeh H (2015) Application of chitosan-based nanocarriers in tumor-targeted drug delivery. Mol Biotechnol 57(3):201–218. https://doi.org/10.1007/s12033-014-9816-3 · DOI
  12. Guidotti G, Brambilla L, Rossi D (2017) Cell-penetrating peptides: from basic research to clinics. Trends Pharmacol Sci 38(4):406–424. https://doi.org/10.1016/j.tips.2017.01.003 · DOI
  13. Guo Y, Zhao Y, Li R, Wang T, Han M et al (2016) Methotrexate nanoparticles prepared with codendrimer from polyamidoamine (PAMAM) and oligoethylene glycols (OEG) dendrons: antitumor efficacy in vitro and in vivo. Scientific Reports 6:28983. https://doi.org/10.1038/srep28983 · DOI
  14. Guterstam P, Madani F, Hirose H, Takeuchi T, Futaki S et al (2009) Elucidating cell-penetrating peptide mechanisms of action for membrane interaction, cellular uptake, and translocation utilizing the hydrophobic counter-anion pyrenebutyrate. Biochim Biophys Acta 1788(12):2509–2517. https://doi.org/10.1016/j.bbamem.2009.09.014 · DOI
  15. Hutchinson J, Muller W (2000) Transgenic mouse models of human breast cancer. Oncogene 19(53):6130–6137. https://doi.org/10.1038/sj.onc.1203970 · DOI
  16. Joncour V, Laakkonen P (2018) Seek & Destroy, use of targeting peptides for cancer detection and drug delivery. Bioorg Med Chem 26(10):2797–2806. https://doi.org/10.1016/j.bmc.2017.08.052 · DOI
  17. Kebebe D, Liu Y, Wu Y, Vilakhamxay M, Liu Z et al (2018) Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers. Int J Nanomed 13:1425–1442. https://doi.org/10.2147/ijn.s156616 · DOI
  18. Kersemans V, Cornelissen B (2010) Targeting the tumour: cell penetrating peptides for molecular imaging and radiotherapy. Pharmaceuticals 3(3):600–620. https://doi.org/10.3390/ph3030600 · DOI
  19. Lee H, Dubikovskaya E, Hwang H, Semyonov A, Wang H et al (2008) Single-molecule motions of oligoarginine transporter conjugates on the plasma membrane of Chinese hamster ovary cells. J Am Chem Soc 130(29):9364–9370. https://doi.org/10.1021/ja710798b · DOI
  20. Lindgren M, Rosenthal-Aizman K, Saar K, Eiriksdottir E, Jiang Y et al (2006) Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. Biochem Pharmacol 71(4):416–425. https://doi.org/10.1016/j.bcp.2005.10.048 · DOI
  21. Ma DX, Qi XR (2010) Comparison of mechanisms and cellular uptake of cell-penetrating peptide on different cell lines. Yao Xue Xue Bao 45(9):1165–1169
  22. Madani F, Lindberg S, Langel L et al (2011) Mechanisms of cellular uptake of cell-penetrating peptides. J Biophys. https://doi.org/10.1155/2011/414729 · DOI
  23. Mäe M, Myrberg H, El-Andaloussi S (2009) Design of a tumor homing cell-penetrating peptide for drug delivery. Int J Pept Res Ther 15(11):11 · DOI
  24. Meikle S, Perugini V, Guildford AL, Santin M (2011) Synthesis, characterisation and in vitro anti-angiogenic potential of dendron VEGF blockers. Macromol Biosci 11(12):1761–1765. https://doi.org/10.1002/mabi.201100267 · DOI
  25. Merrifield RB (1965) Automated synthesis of peptides. Science 150(3693):178–185. https://doi.org/10.1126/science.150.3693.178 · DOI · Paper page
  26. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1–2):55–63 · DOI · Paper page
  27. Myrberg H, Zhang L, Mae M, Langel U (2008) Design of a tumor-homing cell-penetrating peptide. Bioconjug Chem 19(1):70–75. https://doi.org/10.1021/bc0701139 · DOI
  28. Najlah M, D’emanuele A (2006) Crossing cellular barriers using dendrimer nanotechnologies. Curr Opin Pharmacol 6(5):522–527. https://doi.org/10.1016/j.coph.2006.05.004 · DOI
  29. Park J, Ryu J, Kim K, Lee H, Bahn J et al (2002) Mutational analysis of a human immunodeficiency virus type 1 Tat protein transduction domain which is required for delivery of an exogenous protein into mammalian cells. J G Virol 83(5):1173–1181. https://doi.org/10.1099/0022-1317-83-5-1173 · DOI
  30. Perez E, Fernandez A (2015) Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm 93:52–79. https://doi.org/10.1016/j.ejpb.2015.03.018 · DOI
  31. Pilch J, Brown D, Komatsu M, Järvinen T, Yang M et al (2006) Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. Proc Natl Acad Sci USA 103(8):2800–2804. https://doi.org/10.1073/pnas.0511219103 · DOI
  32. Ramsey D, Flynn H (2015) Cell-penetrating peptides transport therapeutics into cells. Pharmacol Ther 154:78–86. https://doi.org/10.1016/j.pharmthera.2015.07.003 · DOI
  33. Raucher D, Ryu J (2015) Cell-penetrating peptides: strategies for anticancer treatment. Trends Mol Med 21(9):560–570. https://doi.org/10.1016/j.molmed.2015.06.005 · DOI
  34. Regberg J, Srimanee A, Langel U (2012) Applications of cell-penetrating peptides for tumor targeting and future cancer therapies. Pharmaceuticals (Basel) 5(9):991–1007. https://doi.org/10.3390/ph5090991 · DOI
  35. Richard JP, Melikov K, Brooks H, Prevot P, Lebleu B et al (2005) Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J Biol Chem 280(15):15300–15306. https://doi.org/10.1074/jbc.M401604200 · DOI
  36. Rodríguez H, Suarez M, Albericio F (2010) A convenient microwave-enhanced solid-phase synthesis of short chain N-methyl-rich peptides. J Pep Sci 16(3):136–140. https://doi.org/10.1002/psc.1209 doi · DOI
  37. Ruoslahti E (2017) Tumor penetrating peptides for improved drug delivery. Adv Drug Deliv Rev 110–111:3–12. https://doi.org/10.1016/j.addr.2016.03.008 · DOI
  38. Shin M, Zhang J, Min K, Lee K, Byun Y et al (2014) Cell-penetrating peptides: achievements and challenges in application for cancer treatment. J Biomed Mater Res A 102(2):575–587. https://doi.org/10.1002/jbm.a.34859 · DOI
  39. Silverman R, Holladay M (2014) The organic chemistry of drug design and drug action, 3rd ed. Elsevier, Oxford
  40. Simberg D, Duza T, Park JH, Essler M, Pilch J et al (2007) Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci USA 104(3):932–936. https://doi.org/10.1073/pnas.0610298104 · DOI
  41. Soler M, Gonzalez-Bartulos M, Figueras E, Ribas X, Costas M et al (2015) Enzyme-triggered delivery of chlorambucil from conjugates based on the cell-penetrating peptide BP16. Org Biomol Chem 13(5):1470–1480. https://doi.org/10.1039/c4ob01875c · DOI
  42. Soriano D, Soler M, González-Bártulos M, Ribas X, Costas M et al (2014) Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties. Org Biomol Chem 12(10):1652–1663. https://doi.org/10.1039/C3OB42422G · DOI
  43. Stanzl E, Trantow B, Vargas J, Wender P (2013) Fifteen years of cell-penetrating, guanidinium-rich molecular transporters: basic science, research tools, and clinical applications. Acc Chem Res 46(12):2944–2954. https://doi.org/10.1021/ar4000554 · DOI
  44. Torchilin V, Levchenko T, Rammohan R, Volodina N, Papahadjopoulos-Sternberg B et al (2003) Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci USA 100(4):1972–1977. https://doi.org/10.1073/pnas.0435906100 · DOI
  45. Vargas JR, Stanzl EG, Teng NN, Wender PA (2014) Cell-penetrating, guanidinium-rich molecular transporters for overcoming efflux-mediated multidrug resistance. Mol Pharm 11(8):2553–2565. https://doi.org/10.1021/mp500161z · DOI
  46. Vives E, Brodin P, Lebleu B (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272(25):16010–16017 · DOI
  47. Wender P, Mitchell D, Pattabiraman K, Pelkey E, Steinman L et al (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci USA 97(24):13003–13008. https://doi.org/10.1073/pnas.97.24.13003 · DOI
  48. Xu L, Zhang H, Wu Y (2014) Dendrimer advances for the central nervous system delivery of therapeutics. ACS Chem Neurosci 5(1):2–13. https://doi.org/10.1021/cn400182z · DOI

Cited by

Sorted by citations

Metadata

Authors
Al-azzawi, S., & Masheta, D.
Venue
Journal of Pharmaceutical Investigation
Publisher
Springer Science and Business Media LLC
Published
2019-01-24
Volume
49
Issue
6
Pages
643-654
ISSN
  • 2093-5552
  • 2093-6214
DOI
10.1007/s40005-018-00424-w
Cited by
28
References
1
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review